Schöbitz, B.; Holsboer, F.; Sutano, W.; Groß, G.; Schönbaum, E.; de Kloet, E. R.: Corticosterone modulates interleukin-evoked fever in the rat. Neuroendocrinology 54, pp. 387 - 395 (1994)

Schöbitz, B.; Sutano, W.; Carey, M. P.; Holsboer, F.; de Kloet, E. R.: Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 60 (2), pp. 124 - 133 (1994)

Schöbitz, B.; Sutano, W.; Carey, M. P.; Holsboer, F.; de Kloet, E. R.: Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid receptor (type 1) in paralell to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 60, pp. 124 - 133 (1994)

Schreiber, W.; Kellner, M.; Heuser-Link, M.; Krieg, J.-C.: Zur Neuropsychiatrie des primären Hyperparathyreoidismus. Deutsche Medizinische Wochenschrift 119, pp. 1076 - 1080 (1994)

Schwarz, J.; Antonini, A.; Kraft, E.; Tatsch, K.; Vogl, T.; Kirsch, C. M.; Leenders, K. L.; Oertel, W. H.: Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in the novo Wilson`s disease. Neurology 44, pp. 1079 - 1082 (1994)

Schweiger, U.; Deuschle, M.; Körner, A.; Lammers, C. H.; Schmider, J.; Gotthardt, U.; Holsboer, F.; Heuser, I.: Decreased lumbar bone mineral density in patients with major depression. American Journal of Psychiatry 151, pp. 1691 - 1693 (1994)

Seifritz, E.; Hemmeter, U.; Pöldinger, W.; Frösch, E. R.; Reul, J. M. H. M.; Holsboer-Trachsler, E.: Differential mood response to synthetic and natural corticosteroids after bilateral adrenalectomy: a case report. Journal of Psychiatric Research 28, pp. 7 - 11 (1994)

Shipp, S.; de Jong, B. M.; Zihl, J.; Frackowiak, R. S. J.; Zeki, S.: The brain activity related to residual motion vision in a patient with bilateral lesions of V5. Brain 117, pp. 1023 - 1038 (1994)

Shoaib, M.; Spanagel, R.: Mesolimbic sites mediate the discriminative stimulus effects of morphine. European Journal of Pharmacology 252, pp. 69 - 75 (1994)

Skutella, T.; Matkowski, A.; Stöhr, T.; Probst, J. C.; Landgraf, R.; Holsboer, F.; Jirikowski, G. T.: Corticotropin - Releasing Hormone (CRH) antisense oligonucleotide treatment alternates social defeat-induced anxiety in rat. Cellular and Molecular Neurobiology 14, pp. 579 - 588 (1994)

Skutella, T.; Probst, C.; Jirikowski, G.; Holsboer, F.; Spanagel, R.: Ventral tegmental area injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior. Neuroscience Letters 167, pp. 55 - 59 (1994)

Skutella, T.; Stöhr, T.; Probst, J. C.; Ramalho-Ortigao, F. J.; Holsboer, F.; Jirikowski, G. F.: Antisense oligonucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: Comparison of phosphorothiotate and 3´-inverted probe performance. Hormone and Metabolic Research 26, pp. 460 - 464 (1994)

Spanagel, R.; Almeida, O. F. X.; Bartl, C.; Shippenberg, T. S.: Evidence that nor-binaltorphimine (nor-BNI) can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology 264, pp. 157 - 162 (1994)

Spanagel, R.; Almeida, O. F. X.; Bartl, C.; Shippenberg, T. S.: Endogenous k-opioid systems in opiate withdrawal: Role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115, pp. 121 - 127 (1994)

Spanagel, R.; Eilbacher, B.; Wilke, R.: Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat. European Journal of Pharmacologs 262, pp. 21 - 26 (1994)

Spanagel, R.; Shoaib, M.: Involvement of mesolimbic k-opioid systems in the discriminative stimulus effects of morphine. Neuroscience 63, pp. 797 - 804 (1994)

Stalla, G. K.; Brockmeier, S. J.; Renner, U.; Newton, C.; Buchfelder, M.; Stalla, J.; Müller, O. A.: SMS 201-995 exerts different effects in vivo and in vitro in ACTH dependent Cushing`s syndrome. European Journal of Endocrinology 130, pp. 125 - 131 (1994)

Stec, I. S. M.; Barden, N.; Reul, J. M. H. M.; Holsboer, F.: Dexamethasone noonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. Journal of Psychiatric Research 28, pp. 1 - 5 (1994)

Steiger, A.; Benkert, O.; Holsboer, F.: Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men. Neuropsychobiology 30, pp. 101 - 105 (1994)

Steiger, A.; Guldner, J.; Colla-Müller, M.; Friess, E.; Sonntag, A.; Schier, T.: Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression. Journal of Psychiatric Research 28, pp. 225 - 238 (1994)